About
Ionis: A force for life
Executive & Leadership Team
Board of Directors
Akcea Therapeutics
Corporate Responsibility
Diversity Equity & Inclusion
DEI Journey
Demographics
DEI Structure
DEI Community
Employee Resource Groups
Ionis Innovation
Technology
Pipeline
Ionis Neurology
+
Innovation in Neurology
Transforming the Management of Neurologic Diseases
RNA-Targeted Regulation of Proteins
Delivering RNA-Targeted Medicines
+
Pipeline
Insights and Medicines
Transforming the Management of Neurology
+
Community Connection
Ion-ARPA Initiative
Grants & Sponsorships
Patients
Patients
Patient Resources
Patient Experiences
Clinical Trials
Expanded Access Policy
Medicines
Investors & media
Overview
Newsroom
Investors & Media
Press Releases
Company Statements
InBriefs
Media Center
Stock Information
Investors & Media
Stock Quote & Chart
Analyst Coverage
Ownership Profile
Financials
Investors & Media
SEC Filings
Annual Reports
Governance
Back To Main
Investors & Media
Governance Documents
Committee Composition
Investor Resources
Investors & Media
Investor FAQs
Settlement Information
Contact Us
Events
Investors & Media
Events
Eye On Ionis
InnovatIONS Podcast
Ionis in the News
Every Moment Matters
Careers
Our Culture
Working at Ionis
Postdoctoral Program
Intern Program
Follow Us
Search for:
RNase H1 characterized enabling design of optimized antisense therapies
Timeline
RNase H1 characterized enabling design of optimized antisense therapies
click
You are now leaving https://www.ionis.com to visit
Continue to site
Cancel
MENU
About
Ionis: A force for life
Executive & Leadership Team
Board of Directors
Akcea Therapeutics
Corporate Responsibility
Diversity Equity & Inclusion
DEI Journey
Demographics
DEI Structure
DEI Community
Employee Resource Groups
Ionis Innovation
Technology
Pipeline
Ionis Neurology
+
Innovation in Neurology
Transforming the Management of Neurologic Diseases
RNA-Targeted Regulation of Proteins
Delivering RNA-Targeted Medicines
+
Pipeline
Insights and Medicines
Transforming the Management of Neurology
+
Community Connection
Ion-ARPA Initiative
Grants & Sponsorships
Patients
Patients
Patient Resources
Patient Experiences
Clinical Trials
Expanded Access Policy
Medicines
Investors & media
Overview
Newsroom
Investors & Media
Press Releases
Company Statements
InBriefs
Media Center
Stock Information
Investors & Media
Stock Quote & Chart
Analyst Coverage
Ownership Profile
Financials
Investors & Media
SEC Filings
Annual Reports
Governance
Back To Main
Investors & Media
Governance Documents
Committee Composition
Investor Resources
Investors & Media
Investor FAQs
Settlement Information
Contact Us
Events
Investors & Media
Events
Eye On Ionis
InnovatIONS Podcast
Ionis in the News
Every Moment Matters
Careers
Our Culture
Working at Ionis
Postdoctoral Program
Intern Program
Follow Us